Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results

BACKGROUND: There is no proven effective treatment for vision loss in central retinal vein occlusion (CRVO). Bevacizumab has been reported in small series with limited follow-up, to have a positive effect in reducing cystoid macular edema (CME) and improving vision in CRVO. PURPOSE: To report long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Manayath, George J, Narendran, V, Al-Kharousi, Nadia, Wali, Upender K
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905183/
https://www.ncbi.nlm.nih.gov/pubmed/20671833
http://dx.doi.org/10.4103/0974-620X.53036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905183/
https://www.ncbi.nlm.nih.gov/pubmed/20671833
http://dx.doi.org/10.4103/0974-620X.53036

Ejemplares similares